Atlas Trials

Dapagliflozin for Cardio-renal Protection After ICU Discharge

Clinical trial NCT07025629 · RECRUITING

Trial details

NCT number
NCT07025629
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Heart Failure and Chronic Kidney Disease Post-ICU
Start date
2025-12-02
Primary completion
2029-01-15
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.